Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
Authors:
- Youdinghuan ChenYCYoudinghuan Chen
- David A. ArmstrongDADavid A. Armstrong
- Lucas A. SalasLSLucas A. Salas
- Haley F. HazlettHHHaley F. Hazlett
- Amanda B. NymonANAmanda B. Nymon
- John A. DessaintJDJohn A. Dessaint
- Daniel S. AridgidesDADaniel S. Aridgides
- Diane L. MellingerDMDiane L. Mellinger
- Xiaoying LiuXLXiaoying Liu
- Brock C. ChristensenBCBrock C. Christensen
- Alix AshareAAAlix Ashare
Open Access
- 10 December 2018
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 10 (1) , 1-10
Abstract
Lung macrophages are major participants in the pulmonary innate immune response. In the cystic fibrosis (CF) lung, the inability of lung macrophages to successfully regulate the exaggerated inflammatory response suggests dysfunctional innate immune cell function. In this study, we aim to gain insight into innate immune cell dysfunction in CF by investigating alterations in DNA methylation in bronchoalveolar lavage (BAL) cells, composed primarily of lung macrophages of CF subjects compared with healthy controls. All analyses were performed using primary alveolar macrophages from human subjects collected via bronchoalveolar lavage. Epigenome-wide DNA methylation was examined via Illumina MethylationEPIC (850 K) array. Targeted next-generation bisulfite sequencing was used to validate selected differentially methylated CpGs. Methylation-based sample classification was performed using the recursively partitioned mixture model (RPMM) and was tested against sample case-control status. Differentially methylated loci were identified by fitting linear models with adjustment of age, sex, estimated cell type proportions, and repeat measurement. RPMM class membership was significantly associated with the CF disease status (P = 0.026). One hundred nine CpG loci were differentially methylated in CF BAL cells (all FDR ≤ 0.1). The majority of differentially methylated loci in CF were hypo-methylated and found within non-promoter CpG islands as well as in putative enhancer regions and DNase hyper-sensitive regions. These results support a hypothesis that epigenetic changes, specifically DNA methylation at a multitude of gene loci in lung macrophages, may participate, at least in part, in driving dysfunctional innate immune cells in the CF lung.Keywords
Funding Information
- National Institutes of Health (RO1HL122372, RO1CA216265, P30GM106394)
- Cystic Fibrosis Foundation (STANTO11RO)
This publication has 49 references indexed in Scilit:
- Cytokine Induced Phenotypic and Epigenetic Signatures Are Key to Establishing Specific Macrophage PhenotypesPLOS ONE, 2013
- Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines IncreasePLOS ONE, 2013
- Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung DiseaseThe Journal of Immunology, 2013
- A novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cellsBiological Chemistry, 2012
- Abnormal Trafficking and Degradation of TLR4 Underlie the Elevated Inflammatory Response in Cystic FibrosisThe Journal of Immunology, 2011
- Mapping the Lung Proteome in Cystic FibrosisJournal of Proteome Research, 2009
- Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic CellsAnnual Review of Immunology, 2009
- Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributionsBMC Bioinformatics, 2008
- Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung DiseaseProceedings of the American Thoracic Society, 2007
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987